Moriña, David
Fernández-Fontelo, Amanda
Cabaña, Alejandra
Puig, Pedro
Monfil, Laura
Brotons, Maria
Diaz, Mireia
Funding for this research was provided by:
Ministerio de Econom?a y Competitividad (MDM-2014-0445)
Fundaci?n Banco Santander
Departament de Salut, Generalitat de Catalunya (0599S/7613/2010)
Instituto de Salud Carlos III (PIE16/00049)
Instituto de Salud Carlos III (PI16/01254)
Instituto de Salud Carlos III (PI16/01056)
Instituto de Salud Carlos III (PI19/01118)
Instituto de Salud Carlos III (R?o Hortega CM15/00061)
Ag?ncia de Gesti? d?Ajuts Universitaris i de Recerca (2017SGR1718)
Ministerio de Ciencia, Innovaci?n y Universidades (RTI2018-096072-B-I00)
Article History
Received: 2 July 2020
Accepted: 4 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: This study was approved by the Clinical Research Ethics Committee and the Institutional Review Board of the University Institute for Primary Care Research (IDIAP) Jordi Gol (P15/106).
: Not applicable.
: The Cancer Epidemiology Research Programme, where LM, MB and MD are affiliated to, has received institutional sponsorship for grants from Merck and GlaxoSmithKline.